Ceribell Rapid Response EEG Speeds Diagnosis and Treatment to Prevent Brain Damage
The new Ceribell Rapid Response EEG provides clinicians at MidMichigan Medical Center – Midland with the diagnostic information they need to make informed treatment decisions quickly and prevent permanent brain damage.
New technology at MidMichigan Medical Center – Midland enables critically ill patients to be diagnosed and treated more quickly for better outcomes. The Ceribell Rapid Response EEG enables clinicians to get electroencephalography (EEG) information in just minutes rather than hours, enabling them to quickly triage patients who may be at risk of harmful brain patterns. The new system can also be used for on-going automatic monitoring that offers real-time feedback on treatment effectiveness. MidMichigan has four Ceribell systems available for immediate access.
“Ceribell is transforming how we monitor and diagnose seizures for Neurotrauma, ICU and ED patients that are at highest risk for poor outcomes,” said Neurohospitalist Faith D. Fuentes, M.D. “Early and accurate treatment of seizure is critical for patients’ outcomes. While we continue to use conventional EEG for applications such as routine or scheduled testing, having 24/7 access to this rapid response system has given us the tools to save lives and improve quality of life in cases where every minute counts.”
Seizures are common in critically ill patients. Ninety percent of these seizures are non-convulsive, showing no outward signs, and can only be detected using EEG. Prolonged seizures of this type lead to permanent brain injury, higher risk of morbidity and mortality, and longer hospital stays. As a result, guidelines from the Neurocritical Care Society recommend EEG should be initiated within 15-60 minutes if providers suspect a condition called status epilepticus (prolonged seizures or multiple seizures in succession.) In addition, the American Heart Association in 2020 published guidelines that require EEG to be promptly performed and interpreted to diagnose seizures in all comatose patients after cardiac arrest.
However, meeting these guidelines has proven difficult due to limitations of conventional EEG systems. Without Rapid Response EEG, even top academic medical centers with 24/7 EEG capability experience an average 4-hour wait-time for conventional equipment, making it difficult to identify which patients are experiencing harmful brain patterns. When relying on clinical judgement alone while waiting for these complex EEG systems, diagnostic accuracy has been shown to be only 65 percent.
The Ceribell Rapid Response EEG system was developed to address those limitations so patients at risk of seizure can be triaged more quickly. The device consists of a simple headband, pocket-sized recorder with intuitive software, and an on-line portal for remote viewing. Ceribell EEG can be set-up by any health care provider. With the Brain Stethoscope and Clarity features, clinicians with no prior background in EEG can triage seizure in minutes. Clinicians using the Brain Stethoscope tool to spot check the EEG were able to identify seizure with remarkable accuracy (96 percent sensitivity). The Clarity feature, which provides 24/7 EEG monitoring and instantaneous alert for brain patterns consistent with status epilepticus, enables rapid identification of new seizures and provides real-time feedback so that physicians can gauge the effectiveness of treatment and optimize care.
“Ceribell founders saw that critically ill seizure patients often suffered as a result of delayed treatment due to lack of EEG,” said Jane Chao, Ph.D., co-founder and CEO of Ceribell. “Some suffered major neurological deficits while others simply didn't make it. It is our mission to ensure no patient suffers unnecessary brain injury as a result of not having prompt EEG. We are excited that visionary hospitals like MidMichigan are already adopting the technology and transforming their EEG capability.”